Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does systemic inflammation lower measured 25-hydroxyvitamin D?

Systemic inflammation causes a rapid, often transient, fall in measured serum 25-hydroxyvitamin D (25[OH]D) levels.

PlausibleJune 19, 202625 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Systemic inflammation can lower measured 25-hydroxyvitamin D because it behaves as a negative acute-phase reactant and is redistributed and used during immune activation.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that during acute inflammatory states 25(OH)D behaves like a negative acute-phase reactant and measured concentrations drop independently of total body stores. Mechanistically this is explained by cytokine-driven reductions in vitamin D–binding proteins, increased capillary leakage redistributing bound 25(OH)D, and immune cell uptake and local conversion of 25(OH)D into active metabolite, creating an extra‑renal sink.

Verified conclusion

Extensive clinical and mechanistic evidence confirms that systemic inflammation significantly lowers measured levels of 25-hydroxyvitamin D [25(OH)D]. During acute inflammatory states, 25(OH)D behaves as a negative acute-phase reactant, meaning its concentration drops rapidly in response to physiological stress rather than reflecting a true change in total body vitamin D stores.

Clinical evidence

The behavior of 25(OH)D as a negative acute-phase reactant is well-documented in surgical, trauma, and critical illness cohorts.

  • Perioperative Trends: In patients undergoing major surgery, such as hip arthroplasty or cardiac procedures, serum 25(OH)D levels typically fall to a nadir within 48–72 hours post-surgery. This drop correlates strongly with the peak of inflammatory markers like C-reactive protein (CRP) and Interleukin-6 (IL-6).
  • Observational Data: Large-scale studies (including NHANES and MESA) demonstrate a robust inverse relationship between systemic inflammatory indices (e.g., neutrophil-to-lymphocyte ratio) and serum 25(OH)D.
  • Recovery and Rebound: Levels generally return toward baseline as inflammation resolves, suggesting that measured "deficiencies" during acute illness are often transient and represent a snapshot of the inflammatory state.

Mechanistic explanations

The decline in circulating 25(OH)D during inflammation is driven by three primary physiological mechanisms:

  • Reduced Carrier Proteins: Over 99% of 25(OH)D is bound to Vitamin D-binding protein (DBP) and albumin. Pro-inflammatory cytokines (IL-6, TNF-α) suppress the hepatic synthesis of these proteins. A reduction in DBP directly results in a lower capacity to hold 25(OH)D in the blood, leading to lower total measured levels.
  • Increased Capillary Permeability: Systemic inflammation increases vascular leakage, allowing the DBP-25(OH)D complex to shift from the intravascular space into extravascular tissues, further diluting serum concentrations.
  • Immune Consumption ("The Sink"): Activated immune cells (macrophages and monocytes) upregulate the enzyme CYP27B1 and the Vitamin D Receptor (VDR). This creates an "extra-renal sink" that pulls 25(OH)D from the circulation to convert it locally into active calcitriol [1,25(OH)₂D]. This localized metabolism fuels the production of antimicrobial peptides (like cathelicidin) and supports immunoregulatory functions.

Bottom line

Systemic inflammation consistently lowers measured 25-hydroxyvitamin D by suppressing its carrier proteins and increasing its utilization by the immune system. Consequently, a low vitamin D level found during acute illness may not reflect a nutritional deficiency, and status should ideally be assessed when the patient is in a non-inflammatory state.

References

  1. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis — pmc.ncbi.nlm.nih.gov ↗
  2. Vitamin D deficiency and supplementation in critical illness—the known knowns and known unknowns — pmc.ncbi.nlm.nih.gov ↗
  3. STUDY OF THE DYNAMICS OF VITAMIN D LEVELS AND IMMUNE STATUS AS SCREENING MARKERS WHEN USING THE ERAS PROGRAM IN OBESE PATIENTS DURING HIP ARTHROPLASTY — surgical-school.com.ua ↗
  4. The Effect of Phototherapy on Systemic Inflammation Measured with Serum Vitamin D-Binding Protein and hsCRP in Patients with Inflammatory Skin Disease — mdpi.com ↗
  5. Autoimmune disease and interconnections with vitamin D — pmc.ncbi.nlm.nih.gov ↗
  6. Why 25-dehydroxyvitamin D is a negative acute-phase reactant — ccjm.org ↗
  7. Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19 — publications.ersnet.org ↗
  8. Low Serum Levels of 25-Hydroxyvitamin D Accompany Severe COVID-19 Because it is a Negative Acute Phase Reactant — pmc.ncbi.nlm.nih.gov ↗
  9. Regulation of human Gc (vitamin D — binding) protein levels: Hormonal and cytokine control of gene expression in vitro — journals.lww.com ↗
  10. Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses — pmc.ncbi.nlm.nih.gov ↗
  11. Letter to the Editor: Vitamin D deficiency in COVID-19: Mixing up cause and consequence — pmc.ncbi.nlm.nih.gov ↗
  12. Importance of the Lipid-Bound Character of Vitamin D Binding Protein in the Evaluation of Vitamin D Status in COVID-19 Patients. — academic.oup.com ↗
  13. L‐cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25‐hydroxy‐vitamin D in Zucker diabetic fatty rats — pmc.ncbi.nlm.nih.gov ↗
  14. Vitamin D and the intracrinology of innate immunity — pmc.ncbi.nlm.nih.gov ↗
  15. Impact of vitamin D on immune function: lessons learned from genome-wide analysis — pmc.ncbi.nlm.nih.gov ↗
  16. Extraskeletal actions of vitamin D — pmc.ncbi.nlm.nih.gov ↗
  17. Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging — pmc.ncbi.nlm.nih.gov ↗
  18. Vitamin D: newly discovered actions require reconsideration of physiologic requirements — pmc.ncbi.nlm.nih.gov ↗
  19. Substrate and Enzyme Trafficking as a Means of Regulating 1,25‐Dihydroxyvitamin D Synthesis and Action: The Human Innate Immune Response — academic.oup.com ↗
  20. Back to the future: a new look at 'old' vitamin D. — pmc.ncbi.nlm.nih.gov ↗
  21. Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses — frontiersin.org ↗
  22. Acute-phase hepatocytes regulate liver sinusoidal cell mediator production. — archsurg.jamanetwork.com ↗
  23. Vitamin D: a negative acute phase reactant — jcp.bmj.com ↗
  24. Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling — dx.plos.org ↗
  25. Vitamin D Metabolism Revised: Fall of Dogmas — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan hs-CRP reflect low-grade systemic inflammation even within the normal range?→Plausible8 sourcesCan rs1420101 CT, rs20541 AG, and rs1801275 AG contribute to type 2 eosinophilic airway inflammation susceptibility?→